XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents disaggregation of revenue by Prenatal, Oncology and Clinical trial support and other services for the three and nine months ended September 30, 2025 and 2024 (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Prenatal
$74,071 $36,601 $191,001 $102,680 
Oncology
8,691 1,138 15,814 1,851 
Clinical trial support and other services
761 680 2,244 2,974 
Total revenues
$83,523  $38,419 $209,059 $107,505